Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
311
-
Total 13F shares, excl. options
-
60M
-
Shares change
-
+3.19M
-
Total reported value, excl. options
-
$7.92B
-
Value change
-
+$549M
-
Put/Call ratio
-
0.97
-
Number of buys
-
157
-
Number of sells
-
-158
-
Price
-
$132.18
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2018
384 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2018.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 311 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60M shares
of 106M outstanding shares and own 56.76% of the company stock.
Largest 10 shareholders include FMR LLC (9.75M shares), VANGUARD GROUP INC (5.21M shares), BlackRock Inc. (4.69M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.5M shares), FRED ALGER MANAGEMENT INC (1.56M shares), STATE STREET CORP (1.47M shares), JENNISON ASSOCIATES LLC (1.21M shares), FIL Ltd (1.07M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.06M shares), and GILDER GAGNON HOWE & CO LLC (986K shares).
This table shows the top 311 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.